HDBuzz interviews Prof Sarah Tabrizi about forthcoming huntingtin lowering / 'gene silencing' trial
Channel: HD Buzz
Date: 2014-10-17

Dr Jeff Carroll interviews Prof Sarah Tabrizi of UCL Institute of Neurology about the forthcoming trial of an antisense oligonucleotide (ASO) drug that aims to reduce production of the mutant huntingtin protein in the brains of Huntington's disease patients. Filmed at the 2014 European Huntington's Disease Network meeting in Barcelona.